Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis (2014)
- Authors:
- USP affiliated authors: DUARTE, ALBERTO JOSE DA SILVA - FM ; BENARD, GIL - FM
- Unidade: FM
- DOI: 10.2340/00015555-1650
- Subjects: PSORÍASE; DERMATOLOGIA
- Language: Inglês
- Imprenta:
- Source:
- Título: Acta dermato-venereologica
- ISSN: 0001-5555
- Volume/Número/Paginação/Ano: v. 94, n. 1, p. 26-31, 2014
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by-nc
-
ABNT
ORTIGOSA, Luciena C. M. et al. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis. Acta dermato-venereologica, v. 94, n. 1, p. 26-31, 2014Tradução . . Disponível em: https://doi.org/10.2340/00015555-1650. Acesso em: 01 out. 2024. -
APA
Ortigosa, L. C. M., Silva, L. C. R., Duarte, A. J. S., Takahashi, M. D. F., & Bebrad, G. (2014). Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis. Acta dermato-venereologica, 94( 1), 26-31. doi:10.2340/00015555-1650 -
NLM
Ortigosa LCM, Silva LCR, Duarte AJS, Takahashi MDF, Bebrad G. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis [Internet]. Acta dermato-venereologica. 2014 ; 94( 1): 26-31.[citado 2024 out. 01 ] Available from: https://doi.org/10.2340/00015555-1650 -
Vancouver
Ortigosa LCM, Silva LCR, Duarte AJS, Takahashi MDF, Bebrad G. Infliximab Does Not Lead to Reduction in the Interferon-gamma and Lymphoproliferative Responses of Patients with Moderate to Severe Psoriasis [Internet]. Acta dermato-venereologica. 2014 ; 94( 1): 26-31.[citado 2024 out. 01 ] Available from: https://doi.org/10.2340/00015555-1650 - Monocyte cytokine secretion in patients with pulmonary tuberculosis differs from that of healthy infected subjects and correlates with clinical manifestations
- Paracoccidioidomycosis: a model for the evaluation of the effects of HIV infection in the natural history of endemic tropical diseases
- Deficient in vitro anti-mycobacterial immunity despite successfullong-term highly active antiretroviral therapy in HIV-infected patients with pas history of tuberculosis infection or disease
- Persistently deficient in vitro anti-mycobacterial immunity despite highly succesful long-term (>4years) HAART: diferential impact of latente tuberculosis infection and previous active disease
- Expression of the costimulatory molecules CD28/CTLA4, CD80/CD86, icos and PD-1 on T-cells and monocytes from Paracoccidiodomycosis (PCM) patients
- Altered expression of stats 1,3,4 and 5 by mononuclear cells from Paracoccidioidomycosis patients
- Altered Ex Vivo Expression of Caspase 8, Caspase 9, and Bcl-2 Is Associated with T-Cell Hyporeactivity in Patients with Paracoccidioidomycosis
- Persistently deficient in vitro anti-mycobacterial immunity despite highly successful long term(>4 years) HAART: Differential impact of latent tuberculosis infection and previous active disease
- Immunological mechnism implicated in recovery or development of acute or chronic forms of paracoccidioidomycosis (PCM)
- Decrease in Mycobacterium tuberculosis specific immune responses in patients with untreated psoriasis living in a tuberculosis endemic area
Informações sobre o DOI: 10.2340/00015555-1650 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas